sb 203580 has been researched along with neuropeptide y in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (neuropeptide y) | Trials (neuropeptide y) | Recent Studies (post-2010) (neuropeptide y) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 10,663 | 152 | 2,269 |
| Protein | Taxonomy | sb 203580 (IC50) | neuropeptide y (IC50) |
|---|---|---|---|
| Neuropeptide Y receptor type 1 | Homo sapiens (human) | 0.0014 | |
| Neuropeptide Y receptor type 2 | Homo sapiens (human) | 0.0003 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Fukuoka, T; Mizushima, T; Noguchi, K; Obata, K; Tokunaga, A; Yamanaka, H | 1 |
1 other study(ies) available for sb 203580 and neuropeptide y
| Article | Year |
|---|---|
Differential activation of MAPK in injured and uninjured DRG neurons following chronic constriction injury of the sciatic nerve in rats.
Topics: Activating Transcription Factor 3; Animals; Antibodies; Behavior, Animal; Brain-Derived Neurotrophic Factor; Butadienes; Cell Count; Constriction; Drug Interactions; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Functional Laterality; Ganglia, Spinal; Gene Expression Regulation; Hyperalgesia; Imidazoles; Immunohistochemistry; In Situ Hybridization; Male; Nerve Growth Factor; Neurons; Neuropeptide Y; Nitriles; p38 Mitogen-Activated Protein Kinases; Pain Measurement; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Time Factors; Transcription Factors | 2004 |